The obligate anaerobe Eubacterium lentum inactivated the cardiac glycoside digitoxin by reducing the double bond in the lactone ring. This conversion was quantitative when the substrate was incubated at a concentration of 10 ,ug/ml. The reduction reaction coincided with the growth phase of the bacterium. The stereochemical configuration at C-20 of the reduction product dihydrodigitoxin was found to be R. Incubation of digitoxigenin and its mono-and bisdigitoxosides individually with E. lentum led to the formation of their respective dihydro derivatives. The configuration at C-20 of these reduced metabolites was also found to be R.
The glycosides digitoxin (DT3) and digoxin (DG3) ( Fig. 1 ) are drugs of choice for the treatment of congestive heart failure and atrial arrhythmias. Whereas it was previously thought that DT3 and DG3 escape extensive metabolic degradation in humans, it is now recognized that the metabolism of these drugs may be significant in some patients (6, 9, 12, 14, 16) . Reduction of the double bond in the lactone ring of DT3 and DG3 leads to the formation of the corresponding dihydro compounds (2, 23) . Recent studies have suggested that more than one-third of the patients taking DG3 excrete detectable quantities of reduced metabolites in the urine. Approximately 10% of the subjects form large amounts (the reduced metabolites constituting up to 52% of total urinary DG3 and metabolites) of the reduction products, which are known to be cardioinactive (9, 16) . The greatly decreased inotropic activity of the reduction products is clinically significant, as indicated by the isolation of the reduced aglycone, dihydrodigoxigenin (DHDGO), from the urine of a patient requiring unusually high doses of DG3 (11) .
Knowledge of DT3 metabolism is very limited because the biotransformation is complex, involving conversion of DT3 to form DG3, hydrolysis of sugar side chains of DT3 and DG3, and epimerization at C-3 of the aglycone (15, (20) (21) (22) . Furthermore, evidence of conjugates and other polar metabolites of the drug has been found, but the products have not been fully characterized (20) . Bodem and Unruh (2) have reported the presence of dihydrodigitoxin (DHDT3) in the plasma of patients on DT3 maintenance therapy. It is possible that the sugar-hydrolyzed metabolites of DT3 (digitoxigenin bisdigitoxoside [DT2], digitoxigenin monodigitoxoside [DT1], and digitoxigenin [DTO]) may also be present in the reduced form, as previously shown for DG3 by Clark and Kalman (5) . Lindenbaum and co-workers have recently discovered that the reduced DG3 metabolites are formed within the gastrointestinal tract in humans as the result of the action of enteric bacteria, with Eubacterium lentum identified as the only species capable of performing this transformation (6, 7, 10) .
Reduction of the 20,22-unsaturated lactone ring of the cardenolides introduces a center of asymmetry at C-20, and Reuning et al. (17) have determined the stereochemistry of dihydrodigoxin (DHDG3) excreted in urine after DG3 administration in humans as 20R. In a previous study it was found that E. lentum is not only capable of reducing DG3 to give 20R-DHDG3, but it can perform the reduction on the sugar-hydrolyzed metabolites of DG3 as well to form the corresponding 20R-dihydro metabolites (18) . Since DHDT3 is known to be an important metabolite of DT3 in humans (2) , it was worthwhile to determine whether this metabolite is also formed by E. lentum.
The major objectives of this study were to confirm the reduction of DT3 and its sugar-hydrolyzed metabolites by E. lentum and to determine the stereochemistry of the reduction products. In addition to chemical analytical techniques, a specific hydroxylation reaction catalyzed by Fusarium roseum was used to convert dihydrodigitoxigenin (DHDTO) formed by E. lentum to 20R-DHDGO of known configuration.
Chemicals and media. Reference DT3, its sugarhydrolyzed metabolites (DT2, DT1, and DTO), and digoxigenin (DGO) were obtained from Boehringer Mannheim Biochemicals, Indianapolis, Ind. The media for growing the bacterial cultures were thioglycolate medium without glucose or indicator (TG) (Difco Laboratories, Detroit, Mich., or BBL Microbiology Systems, Cockeysville, Md.) and brain heart infusion broth (Difco or BBL) with added cysteine (BHIC) (4) .
The fungal cultures, used for transformation of DHDTO to DHDGO, were grown in a medium consisting of the following (per liter of H20): Pharmamedia (Traders Protein Division, Fort Worth, Tex.), 10 g; yeast extract, 5 g; D-glucose, 20 g; NaCl, 5 g; K2HPO4, 5 g (PY).
Instrumentation. The high-performance liquid chromatography (HPLC) system was equipped with a Beckman model 11OA pump (Beckman Instruments, Inc., Fullerton, Calif.), a Rheodyne injection loop (200 ,ul), a normal-phase (Lichrosorb Si 60; Jones Chromatography) column, and a Kratos model FS 970 fluorescence detector (18, 19) . Deuterated solvents were used for determining nuclear magnetic resonsance (NMR) spectra with a Bruker HX-90 or HX-270 spectrometer. Electron impact mass spectra were obtained with a Kratos MS-30 mass spectrometer. Circular dichroism (CD) spectra were obtained with a Jasco model J500A spectropolarimeter.
Microorganisms. E. lentum ATCC 25559 was obtained from the American Type Culture Collection, Rockville, Md., and cultured as previously described (8, 18) . Escherichia Czapek solution (Difco) agar slants in the Ohio State University College of Pharmacy culture collection. Bacterial transformations. The cardenolides were dissolved in ethanol and added to freshly autoclaved TG or BHIC to give an overall concentration of 10 ,ug/ml. The medium was inoculated with 1 ml of a 24-h-old E. lentum TG culture, and the cultures were then incubated at 37°C for 24 h. The use of large volumes (15 ml per tube) of freshly autoclaved medium followed by tight capping of the culture tubes provided a sufficiently anaerobic environment for E. lentum growth on a small scale. After incubation, a 1-ml sample of each culture was extracted with methylene chloride. A previously described HPLC method (18, 19 ) was used to analyze and quantitate the products in the extracts. With this method, the solvent was evaporated, and the extract was then reacted with 1-naphthoyl chloride to obtain fluorescent derivatives. The derivatives were dissolved in a small volume of the mobile phase (hexane-methylene chloride-acetonitrile, 5:1:1) and injected onto the column. A fluorescence detector was used to detect the separated eluates.
Control experiments. The control tubes were prepared by autoclaving the medium inoculated with E. lentum, adding DT3, incubating them for 24 h, and analyzing for DHDT3.
Preparative-scale production of dihydro compounds. DT3 (20 mg in 0.4 ml of ethanol) was added to each of 500-ml Erlenmeyer flasks containing 250 ml of BHIC. Each flask was then seeded with 1 ml of 24-h-old E. lentum broth culture and 0.1 ml of an E. coli broth culture (3) . E. coli contributed to the maintenance of an anaerobic environment in the large-scale cultures and allowed quantitative reduction at higher concentrations of DT3. The cultures were incubated at 37°C for 2 days. After incubation, each culture was extracted twice with double the volume of methylene chloride, and reduction products were purified by chromatography on silica gel columns with methylene chloride-methanol (10:1) as the solvent system. DHDTO and its mono-and bisdigitoxosides (DHDT1 and DHDT2) were prepared by incubating the corresponding unsaturated compounds with E. lentum and E. coli mixed cultures. The culture, extrac-tion, and purification procedures were similar to those described above for DHDT3.
Preparation of DHDTO from DHDT3. DHDT3 (400 mg) prepared by bacterial reduction was dissolved in 130 ml of 60% methanol and divided equally into two Erlenmeyer flasks (250 ml). The pH was adjusted to 1 with 0.1 N HCl.
The flasks were stoppered and shaken for 24 h on a Gyrotory shaker (New Brunswick Scientific Co., Inc., Edison, N.J.) at 250 rpm and 25°C. After the pH of the reaction mixtures was adjusted to 7 with 10% NaOH, the solution was extracted twice with double the volume of chloroform, and the extract was subjected to silica gel column chromatography in a solvent system of methylene chloride-methanol (20:1).
Conversion of DHDTO to DHDGO. A two-stage fermentation procedure was used to generate cultures for transformation experiments. Stage 1 cultures of F. roseum were started by adding an aqueous spore suspension prepared from 7-day-old slant cultures to 100 ml of medium (PY) in a 500-ml Erlenmeyer flask. The stage 1 cultures were incubated at 25°C for 2 days (250 rpm). Stage 2 cultures, used for biotransformation studies, were initiated by adding 10 ml of 2-day-old stage 1 cultures. DHDTO (10 mg) in 0.4 ml of ethanol was added to each of the 1-day-old stage 2 cultures. After 7 days of incubation, the whole cultures were extracted with double the volume of chloroform. Thin-layer chromatographic (TLC) monitoring was performed on 0.25-mm silica gel (PF-254) plates (Merck & Co., Inc., Rahway, N.J.) which were developed in a solvent system of methylene chloride-methanol (20:1). Chromatograms were visualized by spraying the plates with p-anisaldehyde (panisaldehyde, 5 ml; concentrated sulfuric acid, 5 ml; ethanol, 90 ml) and heating. For preparative-scale studies, the chloroform extracts were chromatographed on silica gel columns with a solvent system of methylene chloride-methanol (20:1). DT3, when incubated at a concentration of 10 ,ug/ml for 24 h at 37°C with growing E. lentum cultures, was converted to a major product, often in high yields (100%), as determined by HPLC analysis. HPLC analysis also indicated that the major product was DHDT3. No alteration of DT3 was observed in autoclaved controls. E. lentum did not hydrolyze the sugar side chain of DT3 to give DT2, DT1, or DTO.
To produce large quantities (milligram) of DHDT3, the culture and incubation conditions for reduction of DT3 by E. lentum were examined. Single cultures of E. lentum in large flasks did not convert DT3 to DHDT3 quantitatively; however, when E. coli was used as an oxygen scavenger in mixed-culture experiments, as reported by Bokkenheuser et al. (3), quantitative conversion was observed. E. coli by itself was not able to perform the reduction reaction or any other transformation of DT3.
In a concentration study it was found that total conversion to the reduced metabolite took place when DT3 was incubated with E. lentum and E. coli mixed cultures up to a concentration of 80 ,ug/ml. Above this concentration only partial conversions were seen. In a previous investigation, it was found that the minimum time required for total conversion of DG3 to DHDG3 is 24 h (18) . The same 24-h incubation period was used for DT3 and found to be adequate for quantitative conversion. When DT3 was added to fully grown cultures (24 h old) of E. lentum and incubated for 1 day, less than 10% of the starting material was converted to DHDT3. This indicates that the reduction reaction coincided with the growth phase of the bacterium under the culture conditions used.
Crystalline DHDT3 (383 mg) was obtained after incubating DT3 (500 mg) with E. lentum and E. coli mixed cultures, extraction with methylene chloride, and purification by silica gel column chromatography. The mass spectrum of this metabolite indicated a pseudomolecular ion at mlz 789 (for DHDT3 plus Na+), corresponding to the molecular weight of 766 for DHDT3.
Since the sugar moieties of DHDT3 interfere with the interpretation of various spectra, it was necessary to hydrolyze the sugar side chain and obtain the pure aglycone DHDTO for assignment of stereochemistry. An acid hydrolysis procedure to cleave the sugar side chain, followed by silica gel chromatography, was used to obtain DHDTO (154 mg) from DHDT3 (400 mg).
The CD spectrum of DHDTO showed a positive curve ([0]218 = 125). It is known from previous studies that the sign of the butanolide ring CD curve for -y-lactones is associated with the location of the P carbon relative to the planar lactone ring, and the CD curve is positive when the configuration of the -y-lactone has the P carbon above the plane (1). It has been shown for DHDGO that the positive CD curve is associated with the R configuration at C-20 (1). The positive CD curve observed for DHDTO, based on similar arguments, can be taken as an indication that the configuration at C-20 is R.
Despite the CD evidence, it was decided to confirm the configuration at C-20 of DHDTO produced by incubation with E. lentum cultures. Since the C-20 configuration of the individual epimers (20R and 20S) of DHDGO had already been determined by a combination of NMR spectral analysis, CD spectral analysis, and X-ray crystallography in previous studies (1, 13) , the stereochemistry of the microbially produced reduction product was related to that of reference 20R-DHDGO. The only difference between DHDT0 and DHDGO is the presence of a 12,B-hydroxyl group in the latter compound. A microbial transformation technique was used to insert this hydroxyl group into the DHDTO formed by E. lentum.
Of 12 organisms screened, F. roseum and Penicillium citrinum ATCC 16040 performed the desired 12p-hydroxylation (Fig. 2 ). F. roseum was selected for the preparativescale conversion based on its ability to perform this reaction with about a 90% yield. Incubation of DHDT0 (150 mg), obtained by acid hydrolysis of E. lentum-produced DHDT3, with shaken F. roseum cultures led to the formation of a major product (109 mg). This product was shown to be identical to 20R-DHDGO by TLC, HPLC, mass spectrometry, and NMR spectrometry (1) .
To further define the specificity of this reduction reaction of E. lentum, each of the sugar-hydrolyzed metabolites of DT3 (DT2, DT1, and DTO) was incubated individually with cultures of the bacterium. Analysis of the cultures showed reduction of each of these compounds proceeded with a high yield (often 100%). The stereochemistry of each dihydro derivative was also found to be R by preparative-scale production, acid hydrolysis of glycosides to obtain the aglycone, and comparison of the TLC and HPLC characteristics, as well as the NMR spectra.
In summary, cultures of E. lentum reduced DT3 and its sugar-hydrolyzed metabolites to the corresponding 20Rdihydro derivatives. As previously discussed for DG3, this reduction reaction may contribute significantly to the inactivation of DT3 in some patients (2, 9, 10, 18) . This research was supported by Public Health Service grant NIH 1 R01 AG04119 from the National Institute on Aging and by a grant from the American Heart Association, Central Ohio Chapter.
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